The global market for Tuberculosis Vaccines was valued at US$ 78.3 million in the year 2024 and is projected to reach a revised size of US$ 95 million by 2031, growing at a CAGR of 2.8% during the forecast period.

Tuberculosis Vaccines Market

Tuberculosis (TB) is an infectious disease which is caused by the bacteria called Mycobacterium tuberculosis (MTB). Tuberculosis mainly affects lungs, but can also affect other parts of the body. Typical signs of tuberculosis includes chronic or persistent cough and sputum production. When TB is at an advanced stage the sputum will contain blood and other symptoms include lack of appetite, weight loss, fever, and night sweats.

North American market for Tuberculosis Vaccines is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for Tuberculosis Vaccines is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The major global manufacturers of Tuberculosis Vaccines include Sanofi, Merck, Serum Institute of India, GlaxoSmithKline, Japan BCG Lab, IDT Biologics, GreenSignal Bio Pharma, Taj Pharmaceuticals, Bavarian Nordic, China National Biotec Group, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Tuberculosis Vaccines, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Tuberculosis Vaccines.

The Tuberculosis Vaccines market size, estimations, and forecasts are provided in terms of sales volume (K Doses) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Tuberculosis Vaccines market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Tuberculosis Vaccines manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Tuberculosis Vaccines Market Report

Report Metric	Details
Report Name	Tuberculosis Vaccines Market
Accounted market size in year	US$ 78.3 million
Forecasted market size in 2031	US$ 95 million
CAGR	2.8%
Base Year	year
Forecasted years	2025 - 2031
Segment by Type	Immunotherapeutic Vaccines Booster Vaccines Others
Segment by Application	Hospitals Clinics Others
Consumption by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Asia-Pacific (China, Japan, South Korea, Taiwan) Southeast Asia (India) Latin America (Mexico, Brazil)
By Company	Sanofi, Merck, Serum Institute of India, GlaxoSmithKline, Japan BCG Lab, IDT Biologics, GreenSignal Bio Pharma, Taj Pharmaceuticals, Bavarian Nordic, China National Biotec Group
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Tuberculosis Vaccines manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Tuberculosis Vaccines in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

FAQ for this report

How fast is Tuberculosis Vaccines Market growing?

Ans: The Tuberculosis Vaccines Market witnessing a CAGR of 2.8% during the forecast period 2025-2031.

What is the Tuberculosis Vaccines Market size in 2031?

Ans: The Tuberculosis Vaccines Market size in 2031 will be US$ 95 million.

Who are the main players in the Tuberculosis Vaccines Market report?

Ans: The main players in the Tuberculosis Vaccines Market are Sanofi, Merck, Serum Institute of India, GlaxoSmithKline, Japan BCG Lab, IDT Biologics, GreenSignal Bio Pharma, Taj Pharmaceuticals, Bavarian Nordic, China National Biotec Group

What are the Application segmentation covered in the Tuberculosis Vaccines Market report?

Ans: The Applications covered in the Tuberculosis Vaccines Market report are Hospitals, Clinics, Others

What are the Type segmentation covered in the Tuberculosis Vaccines Market report?

Ans: The Types covered in the Tuberculosis Vaccines Market report are Immunotherapeutic Vaccines, Booster Vaccines, Others

1 Tuberculosis Vaccines Market Overview

1.1 Product Definition

1.2 Tuberculosis Vaccines by Type

1.2.1 Global Tuberculosis Vaccines Market Value Comparison by Type (2024 VS 2031)

1.2.2 Immunotherapeutic Vaccines

1.2.3 Booster Vaccines

1.2.4 Others

1.3 Tuberculosis Vaccines by Application

1.3.1 Global Tuberculosis Vaccines Market Value by Application (2024 VS 2031)

1.3.2 Hospitals

1.3.3 Clinics

1.3.4 Others

1.4 Global Tuberculosis Vaccines Market Size Estimates and Forecasts

1.4.1 Global Tuberculosis Vaccines Revenue 2020-2031

1.4.2 Global Tuberculosis Vaccines Sales 2020-2031

1.4.3 Global Tuberculosis Vaccines Market Average Price (2020-2031)

1.5 Assumptions and Limitations

2 Tuberculosis Vaccines Market Competition by Manufacturers

2.1 Global Tuberculosis Vaccines Sales Market Share by Manufacturers (2020-2025)

2.2 Global Tuberculosis Vaccines Revenue Market Share by Manufacturers (2020-2025)

2.3 Global Tuberculosis Vaccines Average Price by Manufacturers (2020-2025)

2.4 Global Key Players of Tuberculosis Vaccines, Industry Ranking, 2022 VS 2023 VS 2024

2.5 Global Key Manufacturers of Tuberculosis Vaccines, Manufacturing Sites & Headquarters

2.6 Global Key Manufacturers of Tuberculosis Vaccines, Product Type & Application

2.7 Global Key Manufacturers of Tuberculosis Vaccines, Date of Enter into This Industry

2.8 Global Tuberculosis Vaccines Market Competitive Situation and Trends

2.8.1 Global Tuberculosis Vaccines Market Concentration Rate

2.8.2 The Global 5 and 10 Largest Tuberculosis Vaccines Players Market Share by Revenue

2.8.3 Global Tuberculosis Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

2.9 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Global Tuberculosis Vaccines Market Scenario by Region

3.1 Global Tuberculosis Vaccines Market Size by Region: 2020 Versus 2024 Versus 2031

3.2 Global Tuberculosis Vaccines Sales by Region: 2020-2031

3.2.1 Global Tuberculosis Vaccines Sales by Region: 2020-2025

3.2.2 Global Tuberculosis Vaccines Sales by Region: 2026-2031

3.3 Global Tuberculosis Vaccines Revenue by Region: 2020-2031

3.3.1 Global Tuberculosis Vaccines Revenue by Region: 2020-2025

3.3.2 Global Tuberculosis Vaccines Revenue by Region: 2026-2031

3.4 North America Tuberculosis Vaccines Market Facts & Figures by Country

3.4.1 North America Tuberculosis Vaccines Market Size by Country: 2020 VS 2024 VS 2031

3.4.2 North America Tuberculosis Vaccines Sales by Country (2020-2031)

3.4.3 North America Tuberculosis Vaccines Revenue by Country (2020-2031)

3.4.4 U.S.

3.4.5 Canada

3.5 Europe Tuberculosis Vaccines Market Facts & Figures by Country

3.5.1 Europe Tuberculosis Vaccines Market Size by Country: 2020 VS 2024 VS 2031

3.5.2 Europe Tuberculosis Vaccines Sales by Country (2020-2031)

3.5.3 Europe Tuberculosis Vaccines Revenue by Country (2020-2031)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Tuberculosis Vaccines Market Facts & Figures by Region

3.6.1 Asia Pacific Tuberculosis Vaccines Market Size by Region: 2020 VS 2024 VS 2031

3.6.2 Asia Pacific Tuberculosis Vaccines Sales by Region (2020-2031)

3.6.3 Asia Pacific Tuberculosis Vaccines Revenue by Region (2020-2031)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 Taiwan

3.6.10 Indonesia

3.6.11 Thailand

3.6.12 Malaysia

3.6.13 Philippines

3.7 Latin America Tuberculosis Vaccines Market Facts & Figures by Country

3.7.1 Latin America Tuberculosis Vaccines Market Size by Country: 2020 VS 2024 VS 2031

3.7.2 Latin America Tuberculosis Vaccines Sales by Country (2020-2031)

3.7.3 Latin America Tuberculosis Vaccines Revenue by Country (2020-2031)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.8 Middle East and Africa Tuberculosis Vaccines Market Facts & Figures by Country

3.8.1 Middle East and Africa Tuberculosis Vaccines Market Size by Country: 2020 VS 2024 VS 2031

3.8.2 Middle East and Africa Tuberculosis Vaccines Sales by Country (2020-2031)

3.8.3 Middle East and Africa Tuberculosis Vaccines Revenue by Country (2020-2031)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 UAE

4 Segment by Type

4.1 Global Tuberculosis Vaccines Sales by Type (2020-2031)

4.1.1 Global Tuberculosis Vaccines Sales by Type (2020-2025)

4.1.2 Global Tuberculosis Vaccines Sales by Type (2026-2031)

4.1.3 Global Tuberculosis Vaccines Sales Market Share by Type (2020-2031)

4.2 Global Tuberculosis Vaccines Revenue by Type (2020-2031)

4.2.1 Global Tuberculosis Vaccines Revenue by Type (2020-2025)

4.2.2 Global Tuberculosis Vaccines Revenue by Type (2026-2031)

4.2.3 Global Tuberculosis Vaccines Revenue Market Share by Type (2020-2031)

4.3 Global Tuberculosis Vaccines Price by Type (2020-2031)

5 Segment by Application

5.1 Global Tuberculosis Vaccines Sales by Application (2020-2031)

5.1.1 Global Tuberculosis Vaccines Sales by Application (2020-2025)

5.1.2 Global Tuberculosis Vaccines Sales by Application (2026-2031)

5.1.3 Global Tuberculosis Vaccines Sales Market Share by Application (2020-2031)

5.2 Global Tuberculosis Vaccines Revenue by Application (2020-2031)

5.2.1 Global Tuberculosis Vaccines Revenue by Application (2020-2025)

5.2.2 Global Tuberculosis Vaccines Revenue by Application (2026-2031)

5.2.3 Global Tuberculosis Vaccines Revenue Market Share by Application (2020-2031)

5.3 Global Tuberculosis Vaccines Price by Application (2020-2031)

6 Key Companies Profiled

6.1 Sanofi

6.1.1 Sanofi Company Information

6.1.2 Sanofi Description and Business Overview

6.1.3 Sanofi Tuberculosis Vaccines Sales, Revenue and Gross Margin (2020-2025)

6.1.4 Sanofi Tuberculosis Vaccines Product Portfolio

6.1.5 Sanofi Recent Developments/Updates

6.2 Merck

6.2.1 Merck Company Information

6.2.2 Merck Description and Business Overview

6.2.3 Merck Tuberculosis Vaccines Sales, Revenue and Gross Margin (2020-2025)

6.2.4 Merck Tuberculosis Vaccines Product Portfolio

6.2.5 Merck Recent Developments/Updates

6.3 Serum Institute of India

6.3.1 Serum Institute of India Company Information

6.3.2 Serum Institute of India Description and Business Overview

6.3.3 Serum Institute of India Tuberculosis Vaccines Sales, Revenue and Gross Margin (2020-2025)

6.3.4 Serum Institute of India Tuberculosis Vaccines Product Portfolio

6.3.5 Serum Institute of India Recent Developments/Updates

6.4 GlaxoSmithKline

6.4.1 GlaxoSmithKline Company Information

6.4.2 GlaxoSmithKline Description and Business Overview

6.4.3 GlaxoSmithKline Tuberculosis Vaccines Sales, Revenue and Gross Margin (2020-2025)

6.4.4 GlaxoSmithKline Tuberculosis Vaccines Product Portfolio

6.4.5 GlaxoSmithKline Recent Developments/Updates

6.5 Japan BCG Lab

6.5.1 Japan BCG Lab Company Information

6.5.2 Japan BCG Lab Description and Business Overview

6.5.3 Japan BCG Lab Tuberculosis Vaccines Sales, Revenue and Gross Margin (2020-2025)

6.5.4 Japan BCG Lab Tuberculosis Vaccines Product Portfolio

6.5.5 Japan BCG Lab Recent Developments/Updates

6.6 IDT Biologics

6.6.1 IDT Biologics Company Information

6.6.2 IDT Biologics Description and Business Overview

6.6.3 IDT Biologics Tuberculosis Vaccines Sales, Revenue and Gross Margin (2020-2025)

6.6.4 IDT Biologics Tuberculosis Vaccines Product Portfolio

6.6.5 IDT Biologics Recent Developments/Updates

6.7 GreenSignal Bio Pharma

6.7.1 GreenSignal Bio Pharma Company Information

6.7.2 GreenSignal Bio Pharma Description and Business Overview

6.7.3 GreenSignal Bio Pharma Tuberculosis Vaccines Sales, Revenue and Gross Margin (2020-2025)

6.7.4 GreenSignal Bio Pharma Tuberculosis Vaccines Product Portfolio

6.7.5 GreenSignal Bio Pharma Recent Developments/Updates

6.8 Taj Pharmaceuticals

6.8.1 Taj Pharmaceuticals Company Information

6.8.2 Taj Pharmaceuticals Description and Business Overview

6.8.3 Taj Pharmaceuticals Tuberculosis Vaccines Sales, Revenue and Gross Margin (2020-2025)

6.8.4 Taj Pharmaceuticals Tuberculosis Vaccines Product Portfolio

6.8.5 Taj Pharmaceuticals Recent Developments/Updates

6.9 Bavarian Nordic

6.9.1 Bavarian Nordic Company Information

6.9.2 Bavarian Nordic Description and Business Overview

6.9.3 Bavarian Nordic Tuberculosis Vaccines Sales, Revenue and Gross Margin (2020-2025)

6.9.4 Bavarian Nordic Tuberculosis Vaccines Product Portfolio

6.9.5 Bavarian Nordic Recent Developments/Updates

6.10 China National Biotec Group

6.10.1 China National Biotec Group Company Information

6.10.2 China National Biotec Group Description and Business Overview

6.10.3 China National Biotec Group Tuberculosis Vaccines Sales, Revenue and Gross Margin (2020-2025)

6.10.4 China National Biotec Group Tuberculosis Vaccines Product Portfolio

6.10.5 China National Biotec Group Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis

7.1 Tuberculosis Vaccines Industry Chain Analysis

7.2 Tuberculosis Vaccines Raw Material Supply Analysis

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Tuberculosis Vaccines Production Mode & Process Analysis

7.4 Tuberculosis Vaccines Sales and Marketing

7.4.1 Tuberculosis Vaccines Sales Channels

7.4.2 Tuberculosis Vaccines Distributors

7.5 Tuberculosis Vaccines Customer Analysis

8 Tuberculosis Vaccines Market Dynamics

8.1 Tuberculosis Vaccines Industry Trends

8.2 Tuberculosis Vaccines Market Drivers

8.3 Tuberculosis Vaccines Market Challenges

8.4 Tuberculosis Vaccines Market Restraints

9 Research Findings and Conclusion

10 Methodology and Data Source

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

FEATURED COMPANIES

Sanofi

Merck

Serum Institute of India

IDT Biologics

GreenSignal Bio Pharma

Taj Pharmaceuticals

Bavarian Nordic

China National Biotec Group

GlaxoSmithKline

GlaxoSmithKline PLC

Japan BCG Lab

List of Tables

Table 1. Global Tuberculosis Vaccines Market Value Comparison by Type (2024 VS 2031) & (US$ Million)

Table 2. Global Tuberculosis Vaccines Market Value by Application (2024 VS 2031) & (US$ Million)

Table 3. Global Tuberculosis Vaccines Market Competitive Situation by Manufacturers in 2024

Table 4. Global Tuberculosis Vaccines Sales (K Doses) of Key Manufacturers (2020-2025)

Table 5. Global Tuberculosis Vaccines Sales Market Share by Manufacturers (2020-2025)

Table 6. Global Tuberculosis Vaccines Revenue (US$ Million) by Manufacturers (2020-2025)

Table 7. Global Tuberculosis Vaccines Revenue Share by Manufacturers (2020-2025)

Table 8. Global Market Tuberculosis Vaccines Average Price (USD/Dose) of Key Manufacturers (2020-2025)

Table 9. Global Key Players of Tuberculosis Vaccines, Industry Ranking, 2022 VS 2023 VS 2024

Table 10. Global Key Manufacturers of Tuberculosis Vaccines, Manufacturing Sites & Headquarters

Table 11. Global Key Manufacturers of Tuberculosis Vaccines, Product Type & Application

Table 12. Global Key Manufacturers of Tuberculosis Vaccines, Date of Enter into This Industry

Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Tuberculosis Vaccines by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Tuberculosis Vaccines as of 2024)

Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 16. Global Tuberculosis Vaccines Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 17. Global Tuberculosis Vaccines Sales by Region (2020-2025) & (K Doses)

Table 18. Global Tuberculosis Vaccines Sales Market Share by Region (2020-2025)

Table 19. Global Tuberculosis Vaccines Sales by Region (2026-2031) & (K Doses)

Table 20. Global Tuberculosis Vaccines Sales Market Share by Region (2026-2031)

Table 21. Global Tuberculosis Vaccines Revenue by Region (2020-2025) & (US$ Million)

Table 22. Global Tuberculosis Vaccines Revenue Market Share by Region (2020-2025)

Table 23. Global Tuberculosis Vaccines Revenue by Region (2026-2031) & (US$ Million)

Table 24. Global Tuberculosis Vaccines Revenue Market Share by Region (2026-2031)

Table 25. North America Tuberculosis Vaccines Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 26. North America Tuberculosis Vaccines Sales by Country (2020-2025) & (K Doses)

Table 27. North America Tuberculosis Vaccines Sales by Country (2026-2031) & (K Doses)

Table 28. North America Tuberculosis Vaccines Revenue by Country (2020-2025) & (US$ Million)

Table 29. North America Tuberculosis Vaccines Revenue by Country (2026-2031) & (US$ Million)

Table 30. Europe Tuberculosis Vaccines Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 31. Europe Tuberculosis Vaccines Sales by Country (2020-2025) & (K Doses)

Table 32. Europe Tuberculosis Vaccines Sales by Country (2026-2031) & (K Doses)

Table 33. Europe Tuberculosis Vaccines Revenue by Country (2020-2025) & (US$ Million)

Table 34. Europe Tuberculosis Vaccines Revenue by Country (2026-2031) & (US$ Million)

Table 35. Asia Pacific Tuberculosis Vaccines Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)

Table 36. Asia Pacific Tuberculosis Vaccines Sales by Region (2020-2025) & (K Doses)

Table 37. Asia Pacific Tuberculosis Vaccines Sales by Region (2026-2031) & (K Doses)

Table 38. Asia Pacific Tuberculosis Vaccines Revenue by Region (2020-2025) & (US$ Million)

Table 39. Asia Pacific Tuberculosis Vaccines Revenue by Region (2026-2031) & (US$ Million)

Table 40. Latin America Tuberculosis Vaccines Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 41. Latin America Tuberculosis Vaccines Sales by Country (2020-2025) & (K Doses)

Table 42. Latin America Tuberculosis Vaccines Sales by Country (2026-2031) & (K Doses)

Table 43. Latin America Tuberculosis Vaccines Revenue by Country (2020-2025) & (US$ Million)

Table 44. Latin America Tuberculosis Vaccines Revenue by Country (2026-2031) & (US$ Million)

Table 45. Middle East and Africa Tuberculosis Vaccines Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 46. Middle East and Africa Tuberculosis Vaccines Sales by Country (2020-2025) & (K Doses)

Table 47. Middle East and Africa Tuberculosis Vaccines Sales by Country (2026-2031) & (K Doses)

Table 48. Middle East and Africa Tuberculosis Vaccines Revenue by Country (2020-2025) & (US$ Million)

Table 49. Middle East and Africa Tuberculosis Vaccines Revenue by Country (2026-2031) & (US$ Million)

Table 50. Global Tuberculosis Vaccines Sales (K Doses) by Type (2020-2025)

Table 51. Global Tuberculosis Vaccines Sales (K Doses) by Type (2026-2031)

Table 52. Global Tuberculosis Vaccines Sales Market Share by Type (2020-2025)

Table 53. Global Tuberculosis Vaccines Sales Market Share by Type (2026-2031)

Table 54. Global Tuberculosis Vaccines Revenue (US$ Million) by Type (2020-2025)

Table 55. Global Tuberculosis Vaccines Revenue (US$ Million) by Type (2026-2031)

Table 56. Global Tuberculosis Vaccines Revenue Market Share by Type (2020-2025)

Table 57. Global Tuberculosis Vaccines Revenue Market Share by Type (2026-2031)

Table 58. Global Tuberculosis Vaccines Price (USD/Dose) by Type (2020-2025)

Table 59. Global Tuberculosis Vaccines Price (USD/Dose) by Type (2026-2031)

Table 60. Global Tuberculosis Vaccines Sales (K Doses) by Application (2020-2025)

Table 61. Global Tuberculosis Vaccines Sales (K Doses) by Application (2026-2031)

Table 62. Global Tuberculosis Vaccines Sales Market Share by Application (2020-2025)

Table 63. Global Tuberculosis Vaccines Sales Market Share by Application (2026-2031)

Table 64. Global Tuberculosis Vaccines Revenue (US$ Million) by Application (2020-2025)

Table 65. Global Tuberculosis Vaccines Revenue (US$ Million) by Application (2026-2031)

Table 66. Global Tuberculosis Vaccines Revenue Market Share by Application (2020-2025)

Table 67. Global Tuberculosis Vaccines Revenue Market Share by Application (2026-2031)

Table 68. Global Tuberculosis Vaccines Price (USD/Dose) by Application (2020-2025)

Table 69. Global Tuberculosis Vaccines Price (USD/Dose) by Application (2026-2031)

Table 70. Sanofi Company Information

Table 71. Sanofi Description and Business Overview

Table 72. Sanofi Tuberculosis Vaccines Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2020-2025)

Table 73. Sanofi Tuberculosis Vaccines Product

Table 74. Sanofi Recent Developments/Updates

Table 75. Merck Company Information

Table 76. Merck Description and Business Overview

Table 77. Merck Tuberculosis Vaccines Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2020-2025)

Table 78. Merck Tuberculosis Vaccines Product

Table 79. Merck Recent Developments/Updates

Table 80. Serum Institute of India Company Information

Table 81. Serum Institute of India Description and Business Overview

Table 82. Serum Institute of India Tuberculosis Vaccines Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2020-2025)

Table 83. Serum Institute of India Tuberculosis Vaccines Product

Table 84. Serum Institute of India Recent Developments/Updates

Table 85. GlaxoSmithKline Company Information

Table 86. GlaxoSmithKline Description and Business Overview

Table 87. GlaxoSmithKline Tuberculosis Vaccines Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2020-2025)

Table 88. GlaxoSmithKline Tuberculosis Vaccines Product

Table 89. GlaxoSmithKline Recent Developments/Updates

Table 90. Japan BCG Lab Company Information

Table 91. Japan BCG Lab Description and Business Overview

Table 92. Japan BCG Lab Tuberculosis Vaccines Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2020-2025)

Table 93. Japan BCG Lab Tuberculosis Vaccines Product

Table 94. Japan BCG Lab Recent Developments/Updates

Table 95. IDT Biologics Company Information

Table 96. IDT Biologics Description and Business Overview

Table 97. IDT Biologics Tuberculosis Vaccines Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2020-2025)

Table 98. IDT Biologics Tuberculosis Vaccines Product

Table 99. IDT Biologics Recent Developments/Updates

Table 100. GreenSignal Bio Pharma Company Information

Table 101. GreenSignal Bio Pharma Description and Business Overview

Table 102. GreenSignal Bio Pharma Tuberculosis Vaccines Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2020-2025)

Table 103. GreenSignal Bio Pharma Tuberculosis Vaccines Product

Table 104. GreenSignal Bio Pharma Recent Developments/Updates

Table 105. Taj Pharmaceuticals Company Information

Table 106. Taj Pharmaceuticals Description and Business Overview

Table 107. Taj Pharmaceuticals Tuberculosis Vaccines Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2020-2025)

Table 108. Taj Pharmaceuticals Tuberculosis Vaccines Product

Table 109. Taj Pharmaceuticals Recent Developments/Updates

Table 110. Bavarian Nordic Company Information

Table 111. Bavarian Nordic Description and Business Overview

Table 112. Bavarian Nordic Tuberculosis Vaccines Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2020-2025)

Table 113. Bavarian Nordic Tuberculosis Vaccines Product

Table 114. Bavarian Nordic Recent Developments/Updates

Table 115. China National Biotec Group Company Information

Table 116. China National Biotec Group Description and Business Overview

Table 117. China National Biotec Group Tuberculosis Vaccines Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2020-2025)

Table 118. China National Biotec Group Tuberculosis Vaccines Product

Table 119. China National Biotec Group Recent Developments/Updates

Table 120. Key Raw Materials Lists

Table 121. Raw Materials Key Suppliers Lists

Table 122. Tuberculosis Vaccines Distributors List

Table 123. Tuberculosis Vaccines Customers List

Table 124. Tuberculosis Vaccines Market Trends

Table 125. Tuberculosis Vaccines Market Drivers

Table 126. Tuberculosis Vaccines Market Challenges

Table 127. Tuberculosis Vaccines Market Restraints

Table 128. Research Programs/Design for This Report

Table 129. Key Data Information from Secondary Sources

Table 130. Key Data Information from Primary Sources

Table 131. Authors List of This Report

List of Figures

Figure 1. Product Picture of Tuberculosis Vaccines

Figure 2. Global Tuberculosis Vaccines Market Value Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Tuberculosis Vaccines Market Share by Type: 2024 & 2031

Figure 4. Immunotherapeutic Vaccines Product Picture

Figure 5. Booster Vaccines Product Picture

Figure 6. Others Product Picture

Figure 7. Global Tuberculosis Vaccines Market Value by Application (2020-2031) & (US$ Million)

Figure 8. Global Tuberculosis Vaccines Market Share by Application: 2024 & 2031

Figure 9. Hospitals

Figure 10. Clinics

Figure 11. Others

Figure 12. Global Tuberculosis Vaccines Revenue, (US$ Million), 2020 VS 2024 VS 2031

Figure 13. Global Tuberculosis Vaccines Market Size (2020-2031) & (US$ Million)

Figure 14. Global Tuberculosis Vaccines Sales (2020-2031) & (K Doses)

Figure 15. Global Tuberculosis Vaccines Average Price (USD/Dose) & (2020-2031)

Figure 16. Tuberculosis Vaccines Report Years Considered

Figure 17. Tuberculosis Vaccines Sales Share by Manufacturers in 2024

Figure 18. Global Tuberculosis Vaccines Revenue Share by Manufacturers in 2024

Figure 19. Global 5 and 10 Largest Tuberculosis Vaccines Players: Market Share by Revenue in Tuberculosis Vaccines in 2024

Figure 20. Tuberculosis Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024

Figure 21. Global Tuberculosis Vaccines Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Figure 22. North America Tuberculosis Vaccines Sales Market Share by Country (2020-2031)

Figure 23. North America Tuberculosis Vaccines Revenue Market Share by Country (2020-2031)

Figure 24. U.S. Tuberculosis Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 25. Canada Tuberculosis Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 26. Europe Tuberculosis Vaccines Sales Market Share by Country (2020-2031)

Figure 27. Europe Tuberculosis Vaccines Revenue Market Share by Country (2020-2031)

Figure 28. Germany Tuberculosis Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 29. France Tuberculosis Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 30. U.K. Tuberculosis Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 31. Italy Tuberculosis Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 32. Russia Tuberculosis Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 33. Asia Pacific Tuberculosis Vaccines Sales Market Share by Region (2020-2031)

Figure 34. Asia Pacific Tuberculosis Vaccines Revenue Market Share by Region (2020-2031)

Figure 35. China Tuberculosis Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 36. Japan Tuberculosis Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 37. South Korea Tuberculosis Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 38. India Tuberculosis Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 39. Australia Tuberculosis Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 40. Taiwan Tuberculosis Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 41. Indonesia Tuberculosis Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 42. Thailand Tuberculosis Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 43. Malaysia Tuberculosis Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 44. Philippines Tuberculosis Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 45. Latin America Tuberculosis Vaccines Sales Market Share by Country (2020-2031)

Figure 46. Latin America Tuberculosis Vaccines Revenue Market Share by Country (2020-2031)

Figure 47. Mexico Tuberculosis Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 48. Brazil Tuberculosis Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 49. Argentina Tuberculosis Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 50. Middle East and Africa Tuberculosis Vaccines Sales Market Share by Country (2020-2031)

Figure 51. Middle East and Africa Tuberculosis Vaccines Revenue Market Share by Country (2020-2031)

Figure 52. Turkey Tuberculosis Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 53. Saudi Arabia Tuberculosis Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 54. UAE Tuberculosis Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 55. Global Sales Market Share of Tuberculosis Vaccines by Type (2020-2031)

Figure 56. Global Revenue Market Share of Tuberculosis Vaccines by Type (2020-2031)

Figure 57. Global Tuberculosis Vaccines Price (USD/Dose) by Type (2020-2031)

Figure 58. Global Sales Market Share of Tuberculosis Vaccines by Application (2020-2031)

Figure 59. Global Revenue Market Share of Tuberculosis Vaccines by Application (2020-2031)

Figure 60. Global Tuberculosis Vaccines Price (USD/Dose) by Application (2020-2031)

Figure 61. Tuberculosis Vaccines Value Chain

Figure 62. Channels of Distribution (Direct Vs Distribution)

Figure 63. Bottom-up and Top-down Approaches for This Report

Figure 64. Data Triangulation

Figure 65. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Tuberculosis Diagnostic Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Tuberculosis Therapeutics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Tuberculosis TB Detection Market Research Report 2024

Global Mycobacterium Tuberculosis Testing Market Research Report 2024

Global TB Disease Vaccine Market Research Report 2025

Global Tuberculosis Vaccination Market Research Report 2025

Global BCG and Tuberculosis Vaccine Market Research Report 2025

Tuberculosis Testing Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

TB Vaccine Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

BCG Tuberculosis TB Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global BCG Vaccine for Tuberculosis TB Market Research Report 2025

Global BCG Vaccine Market Insights Forecast to 2030

Global TB Vaccines Market Insights Forecast to 2030

Global BCG Vaccination Market Research Report 2025

VPM1002 Tuberculosis BCG Based Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Bacille Calmette Guerin Vaccine Market Research Report 2024

Tuberculosis Prevention and Treatment Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Anti tuberculosis Therapeutics Market Insights Forecast to 2030

Global Tuberculosis Vaccine for Vhildren Market Research Report 2024

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions